Mononeuritis multiplex

Graf J, Imboden J. Vasculitis and peripheral neuropathy. Curr Opin Rheumatol. 2019 Jan;31(1):40-5. Abstract

Beachy N, Satkowiak K, Gwathmey KG. Vasculitic neuropathies. Semin Neurol. 2019 Oct;39(5):608-19. Abstract

Collins MP, Hadden RD. The nonsystemic vasculitic neuropathies. Nat Rev Neurol. 2017 Apr;13(5):302-16.Full text  Abstract

Hellmich B, Sanchez-Alamo B, Schirmer JH, et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. 2023 Mar [Epub ahead of print].Full text  Abstract

1. Collins MP, Kissel JT. Neuropathies with systemic vasculitis. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. 4th ed. Vol. 2. Philadelphia, PA: Elsevier Saunders; 2005:2335-2404.Full text

2. Jennette JC. Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol. 2013 Oct;17(5):603-6. Abstract

3. Said G, Lacroix-Ciaudo C, Fujimura H, et al. The peripheral neuropathy of necrotizing arteritis: a clinicopathological study. Ann Neurol. 1988 May;23(5):461-5. Abstract

4. Hawke SH, Davies L, Pamphlett R, et al. Vasculitic neuropathy: a clinical and pathological study. Brain. 1991 Oct;114 ( Pt 5):2175-90. Abstract

5. Mathew L, Talbot K, Love S, et al. Treatment of vasculitic peripheral neuropathy: a retrospective analysis of outcome. QJM. 2007 Jan;100(1):41-51. Abstract

6. Graf J, Imboden J. Vasculitis and peripheral neuropathy. Curr Opin Rheumatol. 2019 Jan;31(1):40-5. Abstract

7. Beachy N, Satkowiak K, Gwathmey KG. Vasculitic neuropathies. Semin Neurol. 2019 Oct;39(5):608-19. Abstract

8. Langford CA. Vasculitis. J Allergy Clin Immunol. 2003 Feb;111(2 Suppl):S602-12. Abstract

9. Kamesh L, Harper L, Savage CO. ANCA-positive vasculitis. J Am Soc Nephrol. 2002 Jul;13(7):1953-60.Full text  Abstract

10. Dyck PJ, Benstead TJ, Conn, DL, et al. Nonsystemic vasculitic neuropathy. Brain. 1987 Aug;110 ( Pt 4):843-53. Abstract

11. Stone JH. Polyarteritis nodosa. JAMA. 2002 Oct 2;288(13):1632-9. Abstract

12. Cattaneo L, Chierici E, Pavone L, et al. Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis. J Neurol Neurosurg Psychiatr. 2007 Oct;78(10):1119-23. Abstract

13. Nishino H, Rubino FA, DeRemee RA, et al. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol. 1993 Jan;33(1):4-9. Abstract

14. Genta MS, Genta RM, Gabay C. Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum. 2006 Oct;36(2):88-98. Abstract

15. Vollertsen RS, Conn DL, Ballard DJ, et al. Rheumatoid vasculitis: survival and associated risk factors. Medicine (Baltimore). 1986 Nov;65(6):365-75. Abstract

16. Burns TM. Vasculitic neuropathy. Continuum. 2003;9:146-59.

17. Delalande S, de Seze J, Fauchais AL, et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore). 2004 Sep;83(5):280-91. Abstract

18. Ramos-Casals M, Nardi N, Lagrutta M, et al. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine (Baltimore). 2006 Mar;85(2):95-104. Abstract

19. Chapelon C, Ziza JM, Piette JC, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore). 1990 Sep;69(5):261-76. Abstract

20. Golbus J, McCune WJ. Giant cell arteritis and peripheral neuropathy: a report of 2 cases and review of the literature. J Rheumatol. 1987 Feb;14(1):129-34. Abstract

21. Chan WM, Liu DT, Chan AY, et al. ANCA-associated giant cell arteritis presenting with mononeuritis multiplex and central retinal artery occlusion: a case report. Rheumatology (Oxford). 2004 Apr;43(4):529-31. Abstract

22. Campbell SB, Hawley CM, Staples C. Mononeuritis multiplex complicating Henoch-Schonlein purpura. Aust N Z J Med. 1994 Oct;24(5):580. Abstract

23. Collins MP, Hadden RD. The nonsystemic vasculitic neuropathies. Nat Rev Neurol. 2017 Apr;13(5):302-16.Full text  Abstract

24. Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force - second revision. Eur J Neurol. 2021 Nov;28(11):3556-83.Full text  Abstract

25. Griffin JW. Vasculitic neuropathies. Rheum Dis Clin North Am. 2001;27(4):751-60, vi. Abstract

26. Olney RK. AAEM minimonograph #38: neuropathies in connective tissue disease. Muscle Nerve. 1992 May;15(5):531-42. Abstract

27. Said G, Lacroix C. Primary and secondary vasculitic neuropathy. J Neurol. 2005;252(6):633-41. Abstract

28. Moore PM. Immune mechanisms in the primary and secondary vasculitides. J Neurol Sci. 1989 Nov;93(2-3):129-45. Abstract

29. Griem P, Wulferink M, Sachs B, et al. Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today. 1998 Mar;19(3):133-41. Abstract

30. Said G. Necrotizing peripheral nerve vasculitis. Neurol Clin. 1997 Nov;15(4):835-48. Abstract

31. Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med. 1977 Sep;87(3):336-45. Abstract

32. Cacoub P, Maisonobe T, Thibault V, et al. Systemic vasculitis in patients with hepatitis C. J Rheumatol. 2001 Jan;28(1):109-18. Abstract

33. Soulages A, Maisonobe T, Auzou P, et al. Peripheral neuropathy and livedoid vasculopathy. J Neurol. 2022 Jul;269(7):3779-88.Full text  Abstract

34. Burns TM, Schaublin GA, Dyck PJ. Vasculitic neuropathies. Neurol Clin. 2007 Feb;25(1):89-113. Abstract

35. Ten Holder SM, Joy MS, Falk RJ, et al. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother. 2002 Jan;36(1):130-47. Abstract

36. Abdelhakim S, Klapholz JD, Roy B, et al. Mononeuritis multiplex as a rare and severe neurological complication of immune checkpoint inhibitors: a case report. J Med Case Rep. 2022 Feb;16(1):81.Full text  Abstract

37. Baldauf MC, Kapauer M, Joerger M, et al. Pembrolizumab-associated CD8(+) vasculitic mononeuritis multiplex in a patient with mesothelioma. Neurol Neuroimmunol Neuroinflamm. 2021 Jul;8(4):e993.Full text  Abstract

38. Birnbaum J. Infliximab-associated neuropathy in RA patients - the importance of considering the diagnosis of mononeuritis multiplex. Clin Rheumatol. 2007 Feb;26(2):281-2. Abstract

39. Mauermann ML, Ryan ML, Moon JS, et al. Case of mononeuritis multiplex onset with rituximab therapy for Waldenstrom's macroglobulinemia. J Neurol Sci. 2007 Sep 15;260(1-2):240-3. Abstract

40. Bradley WG, Verma A. Painful vasculitic neuropathy in HIV-1 infection: relief of pain with prednisone therapy. Neurology. 1996 Dec;47(6):1446-51. Abstract

41. World Health Organization. Leprosy. Jan 2023 [internet publication].Full text

42. Needham E, Newcombe V, Michell A, et al. Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19. J Neurol. 2021 Aug;268(8):2685-9.Full text  Abstract

43. Taga A, Lauria G. COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era. J Peripher Nerv Syst. 2022 Mar;27(1):4-30.Full text  Abstract

44. Chrestian N, McMillan H, Poulin C, et al. Hereditary neuropathy with liability to pressure palsies in childhood: case series and literature update. Neuromuscul Disord. 2015 Sep;25(9):693-8. Abstract

45. Garg S, Wright A, Reichwein R, et al. Mononeuritis multiplex secondary to sarcoidosis. Clin Neurol Neurosurg. 2005 Feb;107(2):140-3. Abstract

46. Gwathmey KG, Burns TM, Collins MP, et al. Vasculitic neuropathies. Lancet Neurol. 2014 Jan;13(1):67-82. Abstract

47. Said G. Lyme disease. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. 4th ed. Vol. 2. Philadelphia, PA: Elsevier Saunders; 2005:2109-16.

48. Vincent D, Gombert B, Vital A, et al. A case of mononeuropathy multiplex with type II cryoglobulinemia, necrotizing vasculitis and low grade B cell lymphoma. Clin Neuropathol. 2007 Jan-Feb;26(1):28-31. Abstract

49. Monti G, Galli M, Invernizzi F, et al. Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. QJM. 1995 Feb;88(2):115-26. Abstract

50. Hagen EC, Daha MR, Hermans J, et al; EC/BCR Project for ANCA Assay Standardization. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int. 1998 Mar;53(3):743-53.Full text  Abstract

51. Noth I, Strek ME, Leff AR. Churg-Strauss syndrome. Lancet. 2003 Feb 15;361(9357):587-94. Abstract

52. Said G, Lacroix C. Sarcoid neuropathy. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. 4th ed. Vol. 2. Philadelphia, PA: Elsevier Saunders; 2005:2415-25.

53. Vital C, Vital A, Canron MH, et al. Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases. J Peripher Nerv Syst. 2006 Mar;11(1):20-9. Abstract

54. Kawakami T, Soma Y, Kawasaki K, et al. Initial cutaneous manifestations consistent with mononeuropathy multiplex in Churg-Strauss syndrome. Arch Dermatol. 2005 Jul;141(7):873-8. Abstract

55. Lee JE, Shun CT, Hsieh SC, et al. Skin denervation in vasculitic neuropathy. Arch Neurol. 2005 Oct;62(10):1570-3.Full text  Abstract

56. Sabin TD, Swift TR, Jacobson RR. Leprosy. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. 4th ed. Vol. 2. Philadelphia, PA: Elsevier Saunders; 2005:2081-2108.

57. Harrison TR, Fauci AS, Braunwald E, et al. Harrison's principles of internal medicine. 14th ed. Vol 2. New York, NY: McGraw-Hill; 1997:1874-928.

58. Stanson AW, Friese JL, Johnson CM, et al. Polyarteritis nodosa; spectrum of angiographic findings. Radiographics. 2001 Jan-Feb;21(1):151-9. Abstract

59. Pasnoor M, Dimachkie MM, Barohn RJ. Diabetic neuropathy part 2: proximal and asymmetric phenotypes. Neurol Clin. 2013 May;31(2):447-62. Abstract

60. Collins MP, Dyck PJ, Gronseth GS, et al. Peripheral Nerve Society guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst. 2010 Sep;15(3):176-84. Abstract

61. Langford CA, Fauchi AS. The vasculitic syndromes. In: Harrison’s principles of internal medicine, Vol. 2, 21st ed. New York: McGraw Hill LLC, 2022:2802-16.Full text

62. Watts RA, Scott DG, Pusey CD, et al. Vasculitis-aims of therapy. An overview. Rheumatology (Oxford). 2000 Mar;39(3):229-32.Full text  Abstract

63. Hellmich B, Sanchez-Alamo B, Schirmer JH, et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. 2023 Mar [Epub ahead of print].Full text  Abstract

64. Keddie S, Eftimov F, van den Berg LH, et al. Immunoglobulin for multifocal motor neuropathy. Cochrane Database Syst Rev. 2022 Jan 11;1(1):CD004429.Full text  Abstract

65. Koike H, Nishi R, Ohyama K, et al. ANCA-associated vasculitic neuropathies: a review. Neurol Ther. 2022 Mar;11(1):21-38.Full text  Abstract

66. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients. Medicine (Baltimore). 1996 Jan;75(1):17-28.Full text  Abstract

67. Lau JY, Bird GL, Alexander GJ, et al. Effects of immunosuppressive therapy on hepatic expression of hepatitis B viral genome and gene products. Clin Invest Med. 1993 Jun;16(3):226-36. Abstract

68. American Association for the Study of Liver Diseases. HCV guidance: recommendations for testing, managing, and treating hepatitis C. Oct 2022 [internet publication].Full text  Abstract

69. Verma, A. Epidemiology and clinical features of HIV-1 associated neuropathies. J Peripher Nerv Syst. 2001 Mar;6(1):8-13. Abstract

70. Ungprasert P, Sukpornchairak P, Moss BP, et al. Neurosarcoidosis: an update on diagnosis and therapy. Expert Rev Neurother. 2022 Aug;22(8):695-705. Abstract

71. Statkute L, Oyama Y, Barr WG, et al. Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis. Ann Rheum Dis. 2008 Jul;67(7):991-7. Abstract

72. Kötter I, Daikeler T, Amberger C, et al. Autologous stem cell transplantation of treatment-resistant systemic vasculitis: a single center experience and review of the literature. Clin Nephrol. 2005 Dec;64(6):485-9. Abstract

73. Schneider C, Wunderlich G, Bleistein J, et al. Lymphocyte antigens targetable by monoclonal antibodies in non-systemic vasculitic neuropathy. J Neurol Neurosurg Psychiatry. 2017 Sep;88(9):756-60. Abstract

74. Collins MP, Periquet MI, Mendell JR, et al. Nonsystemic vasculitic neuropathy: insights from a clinical cohort. Neurology. 2003 Sep 9;61(5):623-30. Abstract